You have closed, or you are close to signing, and the investment thesis now has to survive contact with the operating reality. The board deck says pricing, AI enablement, sales efficiency, cloud savings, product velocity, integration, or professionalisation. The management team is already busy. The sponsor needs confidence that the first 100 days will not become a polite reporting exercise. That is usually when someone searches for a value creation partner for private equity.
In my experience, the phrase means different things depending on where the deal sits. A lower mid-market founder-led business may need a standing second opinion on technology, go-to-market systems, hiring sequence, and operating cadence. A larger platform may need a sharper 100-day value creation plan, a board-level operator to challenge assumptions, or an interim technology leader until the right permanent executive is in place. The useful answer is rarely more activity. It is better sequencing.
What buyers actually mean by value creation partner for private equity
Most sponsors are not looking for another thick strategy document. They are trying to reduce ambiguity around a few practical questions:
- Which initiatives matter now? Not every diligence finding belongs in the first 100 days. The work is deciding what affects the underwriting case, what derisks the platform, and what can wait.
- Who is accountable? A value creation plan without named owners, weekly cadence, and decision rights becomes theatre.
- Where is management overloaded? The team that got the company here may not have the bandwidth or experience for the next operating model.
- Which assumptions need proof? If the deal model depends on pricing power, lower churn, faster product delivery, lower infrastructure cost, or a new acquisition channel, the first step is not a slogan. It is evidence.
- How does the sponsor stay close without becoming the operator? Good value creation support gives the board better visibility without turning every weekly meeting into a sponsor-led management session.
That is why I prefer the term partner only when there is an advisory relationship behind it. I am not an agency and I do not sell a bench of consultants. I take a small number of personal engagements where I sit alongside the sponsor, operating partner, CEO, or CTO as a fractional operating partner, interim technology leader, or board advisor. If execution capacity is needed after the plan is clear, DevriX is one place it can come from. But the offer starts with judgement, prioritisation, and operating discipline.
The 100-day plan is a forcing function, not a template
A 100-day value creation plan has a reputation for being formulaic: diagnose, prioritise, implement, report. That sequence is directionally right, but it misses the main point. The first 100 days are a forcing function for choices.
In a private equity context, choices have consequences. If you prioritise enterprise sales motion, you may slow down product-led growth experiments. If you push cloud cost optimisation too aggressively, you may distract the engineering team from roadmap commitments. If you replace systems immediately, you may create operational drag before the leadership team has stabilised. If you avoid change to preserve goodwill, you may lose two quarters before addressing known constraints.
The job is not to make the plan look comprehensive. The job is to make the next dozen decisions clearer, faster, and tied to the investment thesis.
For technology-heavy businesses, I usually look at four layers. First, revenue systems: CRM hygiene, funnel conversion, marketing attribution, sales productivity, customer success workflows, pricing and packaging. Second, product and engineering: roadmap governance, release cadence, technical debt, architecture risk, QA, security, and hiring shape. Third, data and operating visibility: board metrics, cohort reporting, contribution margin, support burden, and executive dashboards. Fourth, AI and automation: not a vague AI initiative, but specific workflows where margin, speed, or service quality can improve.
That analysis is only useful if it turns into a small number of decisions. A typical 100-day plan should separate immediate stabilisation, value proof points, and structural changes. Immediate stabilisation protects the business. Value proof points test the deal thesis. Structural changes build the machine for the rest of the hold period.
A decision framework for choosing the right partner
When a sponsor asks me whether they need a value creation partner for private equity, I usually walk through six questions.
1. Is the value creation thesis operational or financial?
If the plan is mainly debt structure, reporting, working capital, or add-on modelling, the right answer may be the CFO, the deal team, or a finance transformation specialist. If the thesis depends on product velocity, pricing execution, go-to-market systems, platform scalability, AI enablement, digital acquisition, or technical leadership, an operator with technology and growth experience is more relevant.
2. Is the management team aligned on the problem?
Misalignment is normal after a transaction. The CEO may think the issue is sales discipline. The CTO may think it is legacy architecture. The sponsor may think it is management information. A good advisor does not simply pick a side. I would make the disagreement explicit, link it to the value creation case, and create a decision path.
3. What must be true by day 30, day 60, and day 100?
Day 100 is too late for the first honest readout. By day 30, the team should know the baseline and the few bottlenecks that matter. By day 60, there should be initiative owners, operating cadence, and first evidence from tests or interventions. By day 100, the board should know which initiatives are working, which need more resource, and which should be killed.
4. Who has authority to change the operating system?
A value creation partner can advise, challenge, and coordinate. But if the CEO does not want the cadence, or the sponsor will not back the hard tradeoffs, the work becomes decorative. Before starting, I want clarity on escalation, decision rights, and what level of management engagement is expected.
5. Is this a one-off plan or a standing advisory need?
Some situations need a sharp sprint: translate diligence into a 100-day value creation plan and hand it to the CEO and board. Others need a retained advisor for the first two or three quarters, especially if technology, data, or go-to-market execution is central to the deal case. The difference matters because the operating rhythm changes.
6. What will you stop doing?
This is the question many plans avoid. Management teams do not fail because they lack initiatives. They fail because the initiative stack becomes larger than the organisation can absorb. If the company adds five new value creation workstreams but keeps every legacy project, the plan is already compromised.
Comparison of common options
There are several ways to cover the value creation role. None is universally right.
- Internal operating partner: Best when the sponsor has the domain expertise, capacity, and authority to drive the plan. The tradeoff is bandwidth across multiple portfolio companies and potential blind spots from being too close to the investment thesis.
- Large consulting firm: Useful for broad transformation, benchmarking, PMO, or when the board wants institutional coverage. The tradeoff is cost, handoff risk, and a tendency to produce more process than operating judgement in smaller companies.
- Specialist functional advisor: Strong when the issue is specific: pricing, RevOps, cybersecurity, architecture, finance systems, or M&A integration. The tradeoff is that specialists may optimise their function rather than the full value creation agenda.
- Interim executive: Appropriate when there is a real leadership gap, such as no CTO, weak product leadership, or a CRO transition. The tradeoff is that an interim operator can become absorbed by daily management and lose the board-level pattern view.
- Fractional operating partner or board advisor: Best when the sponsor needs senior judgement, challenge, prioritisation, and a standing second opinion without installing a large delivery team. The tradeoff is that execution still needs owners inside the company or through carefully selected support.
The mistake is buying the wrong format because the label sounds familiar. A value creation partner for private equity should match the constraint. If the constraint is capacity, add capacity. If the constraint is poor decisions, add judgement. If the constraint is weak cadence, install cadence. If the constraint is missing leadership, fill the leadership gap.
What a good 100-day value creation plan should contain
I like plans that are short enough to be used and specific enough to be uncomfortable. The core components are straightforward:
- Investment thesis translation: A plain-language version of how value is expected to be created, where technology and operations contribute, and which assumptions are still unproven.
- Baseline: Current metrics, systems, team structure, cost drivers, delivery cadence, funnel health, customer risk, and technical constraints.
- Initiative map: A small set of workstreams with owners, effort, dependencies, expected impact, and timing.
- Decision log: The major choices the CEO, sponsor, and board must make, with the evidence required to make them.
- Operating cadence: Weekly management rhythm, sponsor check-ins, board reporting, and escalation rules.
- Stop list: Projects to pause, combine, or kill so the company has the oxygen to execute.
- First proof points: Specific tests that can validate or falsify the plan before large commitments are made.
That last point matters. A good 100-day plan does not pretend to know everything on day one. It creates the conditions for faster learning. For example, if the thesis assumes improved sales productivity, the first proof point may be pipeline hygiene, conversion analysis, offer packaging, or sales cycle segmentation. If the thesis assumes technology scalability, the proof point may be incident data, deployment cadence, cloud spend drivers, architectural review, or engineering throughput. The board should be able to see movement without being sold a vanity milestone.
When a value creation partner is the wrong tool
There are situations where hiring a value creation partner is not the right answer.
- The sponsor already knows the answer and only wants validation. If the decision is made, bring in execution capacity or communicate the decision directly. Do not dress confirmation as advisory work.
- The CEO is not bought in. A forced advisor relationship can create resistance and shadow management. Alignment at the outset is not optional.
- The company is in crisis. If cash, customer churn, security, or delivery failure is acute, the first need may be turnaround control, incident response, or interim executive authority rather than a broad value creation plan.
- The plan depends on resources that will not be funded. If the board will not back hiring, systems, commercial tests, or technical remediation, the plan should be narrowed rather than pretending otherwise.
- The issue is purely transactional. For a narrow QoE item, tax matter, or legal issue, use the appropriate specialist.
I would rather say no to the wrong engagement than create a polished plan that nobody has the mandate to execute. In private equity, wasted quarters are expensive. So is fake alignment.
How sponsors should brief the role
A tight brief saves time. I would ask for the investment memo, diligence outputs, management presentation, current KPI pack, org chart, product or technology roadmap if relevant, and the board's current concerns. I would also want separate conversations with the sponsor, CEO, and functional leaders before making recommendations.
The brief should state what is in scope and what is not. For example: assess technology risk, convert diligence findings into a 100-day plan, establish the first operating cadence, pressure-test AI opportunities, advise the CTO search, and prepare a board-ready value creation roadmap. That is a workable scope. A vague instruction to help with growth is not.
The best sponsor relationships also define the advisory posture. Am I advising the sponsor privately? Sitting with the CEO as a retained operating advisor? Acting as interim technology leadership? Joining board meetings as an external challenge point? Each model can work, but mixing them without clarity creates confusion.
How I would approach this
If I were coming in after signing, I would start by translating the deal thesis into a short operating agenda. I would separate the non-negotiables from the nice-to-haves, identify the constraints in management capacity, and build a 30-60-100 day plan that the CEO can actually run. I would then install a light cadence: weekly workstream review, decision log, sponsor readout, and a board version that focuses on evidence rather than activity.
If the company is still pre-close, I would keep the work sharper: confirm the major assumptions, identify the first 100-day moves, and flag anything that changes the value creation case. If the deal has already closed and technology or growth execution is central to the thesis, I would usually recommend a focused 100-Day Value Creation Plan first. If the sponsor needs an ongoing second opinion across the first few quarters, a Fractional Retainer is the cleaner model.
The point is not to add another advisor to the cap table ecosystem. The point is to make the value creation agenda specific, sequenced, and accountable early enough that the hold period starts with momentum rather than drift.